These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 8203435)

  • 1. Gonadotropin-releasing hormone agonist use before hysterectomy.
    Stovall TG; Summit RL; Washburn SA; Ling FW
    Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myomectomy after selective preoperative treatment with a gonadotropin releasing hormone analog.
    Hutchins FL
    J Reprod Med; 1992 Aug; 37(8):699-702. PubMed ID: 1432986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas.
    Stovall TG; Ling FW; Henry LC; Woodruff MR
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1420-3; discussion 1423-5. PubMed ID: 1904681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
    Saltiel E
    Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal hysterectomy by uterine morcellation: an efficient, non-morbid procedure.
    Mazdisnian F; Kurzel RB; Coe S; Bosuk M; Montz F
    Obstet Gynecol; 1995 Jul; 86(1):60-4. PubMed ID: 7784024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does medical debulking with gonadotrophin-releasing hormone agonist facilitate vaginal hysterectomy with a moderate enlarged uterus? A randomized control study.
    Elzaher MA; Moawad A; Madkour WA; Ali M; Salah Eldin Abdel Hamid AM; Zaheer H
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):326-30. PubMed ID: 23537617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study.
    Reinsch RC; Murphy AA; Morales AJ; Yen SS
    Am J Obstet Gynecol; 1994 Jun; 170(6):1623-7; discussion 1627-8. PubMed ID: 8203418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas.
    Iverson RE; Chelmow D; Strohbehn K; Waldman L; Evantash EG
    Obstet Gynecol; 1996 Sep; 88(3):415-9. PubMed ID: 8752251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of GnRH agonists in preoperative treatment of complicated uterine myomata].
    Campusano C; Zapata R; Bianchi M; Badia JI; Arteaga E
    Rev Chil Obstet Ginecol; 1993; 58(2):150-4. PubMed ID: 8209044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine hysterectomy for large asymptomatic uterine leiomyomata: a reappraisal.
    Reiter RC; Wagner PL; Gambone JC
    Obstet Gynecol; 1992 Apr; 79(4):481-4. PubMed ID: 1553162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
    Mizutani T; Sugihara A; Honma H; Komura H; Nakamuro K; Terada N
    Gynecol Endocrinol; 2005 Feb; 20(2):80-3. PubMed ID: 15823826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH analogue-induced uterine shrinkage enabling a vaginal hysterectomy and repair in large leiomyomatous uteri.
    Schneider D; Golan A; Bukovsky I; Pansky M; Caspi E
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):540-1. PubMed ID: 1831252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of leuprorelin acetate depot in symptomatic fibromatous uteri: the Italian Multicentre Trial.
    Serra GB; Panetta V; Colosimo M; Romanini C; Lafuenti GB; Garcea N; Votano S; Agatensi L
    Clin Ther; 1992; 14 Suppl A():57-73. PubMed ID: 1606594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.
    Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT
    Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of GnRH agonist before hysterectomy: a cost simulation.
    Bradham DD; Stovall TG; Thompson CD
    Obstet Gynecol; 1995 Mar; 85(3):401-6. PubMed ID: 7862380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal hysterectomy and oophorectomy in women with 12-20 weeks' size uterus.
    Sahin Y
    Acta Obstet Gynecol Scand; 2007; 86(11):1359-69. PubMed ID: 17963064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presurgical treatment of uterine fibroids by using gonadotropin-releasing hormone agonists.
    Falsetti L; Mazzani MD; Rubessa S; Ruggeri C
    Acta Eur Fertil; 1992; 23(1):29-32. PubMed ID: 1293897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal hysterectomy in generally considered contraindications to vaginal surgery.
    Paparella P; Sizzi O; Rossetti A; De Benedittis F; Paparella R
    Arch Gynecol Obstet; 2004 Sep; 270(2):104-9. PubMed ID: 12856131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.